Ginkgo bioworks announces proposed public offering of class a common stock

Boston , nov. 15, 2022 /prnewswire/ -- ginkgo bioworks holdings, inc. (nyse: dna) ("ginkgo"),which is building the leading platform for cell programing and biosecurity, today announced that it intends to offer and sell $100 million of its class a common stock in an underwritten public offering. as part of this offering, ginkgo intends to grant the underwriter a 30-day option to purchase up to an additional $15 million of the shares of class a common stock.
DNA Ratings Summary
DNA Quant Ranking